2型炎症和性别的效果改变对喘恶化率的影响
Trisha Agarwal1, Ryan Peterson2, Guillermo Jimenez3
1University of Colorado School of Medicine, Aurora, CO.
CHEST pulmonary
|November 28, 2025
概括
2型高炎症预示着喘恶化率的增加,女性的发病率更高. 绝对乙酸细胞计数 (AEC) 显示了与恶化的剂量依赖关系,这表明针对特定患者群体的向治疗.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 在医疗保健中的数据科学.
背景情况:
- 喘恶化是一个重要的临床问题.
- 以前关于恶化预测因素的研究往往省略了2型 (T2) 炎症标志物.
- 了解T2炎症的作用对于有效的喘管理至关重要.
研究的目的:
- 在大型电子健康记录数据库中识别喘恶化率的预测因素.
- 调查T2炎症,女性性别和肥胖之间的潜在相互作用,以及喘恶化率.
主要方法:
- 这是一项回顾性队列研究,使用了来自70,939名喘患者的电子健康记录数据.
- 由口服皮质类固醇爆发处方定义的喘恶化率.
- 分析包括T2高炎症 (绝对乙酸细胞数≥300细胞/μL),BMI和性别作为预测指标,使用负二项式模型.
主要成果:
- 患有T2高炎症的患者表现出更高的调整后恶化率 (IRR 1.13).
- 绝对的乙氨基基酸计数显示了与恶化频率的剂量依赖关系.
- 通过性别观察到显著的效果修饰,T2高炎症的女性经历了加剧率的增加.
结论:
- 高T2炎症与剂量依赖的喘恶化率增加有关.
- 这项研究是第一个报告喘恶化中因性别和T2状态而改变效果的研究.
- 识别这些高风险患者可以指导使用T2向生物疗法来降低恶化率.
相关概念视频
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Asthma-III: Symptoms and Complications
3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.2K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K


